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Abstract
The Semantic Web offers an ideal platform for representing and linking biomedical
information, which is a prerequisite for the development and application of analytical
tools to address problems in data-intensive areas such as systems biology and
translational medicine. As for any new paradigm, the adoption of the Semantic Web
offers opportunities and poses questions and challenges to the life sciences scientific
community: which technologies in the Semantic Web stack will be more beneficial
for the life sciences? Is biomedical information too complex to benefit from simple
interlinked representations? What are the implications of adopting a new paradigm
for knowledge representation? What are the incentives for the adoption of the
Semantic Web, and who are the facilitators? Is there going to be a Semantic Web
revolution in the life sciences?
We report here a few reflections on these questions, following discussions at the
SWAT4LS (Semantic Web Applications and Tools for Life Sciences) workshop series, of
which this Journal of Biomedical Semantics special issue presents selected papers
from the 2009 edition, held in Amsterdam on November 20th.
Introduction
The increasing amounts of data being gathered on biological systems and the conver-
gence of different disciplines are leading to entirely new areas of research, from
systems biology to translational and personalized medicine. These, in turn, promise to
have a significant impact on our society. This promise relies on the multi-disciplinary
integration and analysis of data. However, biomedical information is challenging: it is
heterogeneous, fragmented and characterized by a complex semantics [1]. The many
properties and attributes that characterize biological phenomena give biomedical data
its multi-dimensional nature. Additional complexity arises through layers of systems
and entities that interact at multiple levels of granularity, from the molecular level to
the macro level of the organism and environment.
The Semantic Web is a set of standards and technologies which provides tools to
address such challenges, by enabling an explicit characterization of the semantics of
information, by which heterogeneous and distributed information can be linked. For
example, the Semantic Web can easily represent the network model of molecular and
system interactions that researchers refer to in pathways. Such pathways may be repre-
sented as paths through a graph or (semantic) web of connections between information
resources representing the entities which participate in such pathways. The first mention
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of the potential of these technologies to address the increasing complexity of life
sciences information dates back to 2001 [2], just after the completion of the Human
Genome Project. Since then, a number of papers have discussed the potential impact of
these technologies [3-6], have reported success stories [7], have argued over their limits
[8,9] or have presented reviews on state of the art of their application [10-12].
The Semantic Web is now becoming mature. Some of its standards, such as RDF
(Resource Description Framework) and SPARQL (an RDF Query Language), are sup-
ported by several tools which are produced by an emerging ecosystem of enterprises.
These tools and standards are being adopted both by governments and by major infor-
mation industry players [13-17]. Outside the life sciences domain, recent developments
in the Web community demonstrate that key players are adopting the Semantic Web
standards. For example, Twitter, Facebook, Drupal, and Google have each separately
announced various ways to produce and consume RDF using their APIs. Twitter
announced a new feature called Annotations that enables users to add rich metadata
to their tweets. Facebook has adopted RDF-based Open Graph Protocol to link sites to
Facebook. Drupal 7 includes RDF mappings for the most common content types and
allows Drupal-based distributions to predefine their data structure using RDF, with
SPARQL integration being promised in the near future. Google has started to recom-
mend the GoodRelations ontology for RDFa (RDF-in- attributes) markup of Web
pages for better e-commerce representation in search results lists. These small, but
significant, developments show that important companies, projects, and institutions on
the Web are seeing the value of the Semantic Web.
Many life sciences researchers have been early adopters of Semantic Web technologies.
SWAT4LS (Semantic Web Applications and Tools for Life Sciences) is a workshop series
whose main objective is to foster a critical discussion about the possibilities, limitations,
and adoption of the Semantic Web in the life sciences and in biomedical research.
In addition to previous editions of this workshop, SWAT4LS 2008 [18] and SWAT4LS
2009 [19], the Semantic Web has been the focus of both the 2010 edition of the
Bio-Ontology workshop [20] and the Biohackathon [21]. Life sciences also played a
prominent role in many sessions of the 2010 Semantic Technology Conference [22].
The Concept Web Alliance [23], whose initial focus since inception in 2009 has been in
the life sciences, has also been founded on the Semantic Web principles and technolo-
gies. The importance of the Semantic Web has also been recognized by research spon-
sors: the National Center for Biomedical Ontologies (NCBO) at Stanford, whose
BioPortal offers a set of Biomedical Semantic Web services, is receiving another round
of funding as one of the NIH National Centers for Biomedical Computing in the U.S.
It is perhaps surprising, then, that the number of papers which explicitly mention the
term “Semantic Web” in Pubmed has shown a decline in the last two years. Figure 1
shows the trend over the period from 2001 to 2010, in comparison with a few other
keywords representing related technologies. While the terms “website”, “internet” and
“ontology” are appearing more and more in abstracts, the term “Semantic Web” which
ought to encompass them, is not. Could this be due to a general preference for the terms
that refer to particular aspects of the Semantic Web such as “ontology” and “linked data”?
Clearly, Figure 1 is only a weak and imprecise indication of the impact of a technology, as
seen through the frequency of its related terms in literature. Nevertheless, this observation
calls for some thoughts on why we do not see more of Semantic Web in life sciences.
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Which Semantic Web?
The two words that make up the term “Semantic Web” reveal its two cores: “the web” and
“the semantics”. Indeed, one aim of the Semantic Web is to make data accessible on the
Web (i.e. using web protocols such as HTTP), the most prominent example of this aim
being perhaps represented by Linked Data [24]. In life sciences, only a few integration
solutions focus on this “data access” aspect (we cite, as examples, Bio2RDF [25] and
LODD [26]).
On the other hand, the desire to semantically characterize biological data is older
than the web. Hence, the development of biomedical ontologies is already an active
field, and is relatively mature in terms of use cases, infrastructures and methodologies
[27,28]. These two cores of the Semantic Web are not clear-cut: ontologies are used to
provide an interpretation of information presented in RDF [29]. OWL (the Ontology
Web Language) is increasingly adopted for the definition of bio-ontologies [30,31].
However, there are still many life sciences information resources which expose ontolo-
gies and information by using custom technologies. The Semantic Web is not a mono-
lithic set of technologies. “Which” Semantic Web we will see in the life sciences is still
an open question: which balance of “web” and “semantics” will it involve?
What does the data mean?
Once people start sharing data as RDF, they are confronted with a challenge that was
never apparent before, often because it simply was not attempted: large-scale semantics-
based data integration. The use of common identifiers to refer to the same data items can
ease data integration tremendously, making an otherwise costly mapping and alignment
process unnecessary. This is the intention of the Shared Names initiative, as well as of the
Figure 1 Number of papers in Pubmed which contain the keyword “Semantic Web”, and related
keywords, published during the years 2001-2010. Numbers of papers in Pubmed from 2001 to 2010
which contain in the title or abstract the keywords “Semantic Web”, “Website”, “Internet”, “Relational
database”, “XML”, “Ontology”. The number of papers for 2010 is linearly extrapolated from the total number
of papers published until November 2010. The numbers reported are first normalized by the total number
of papers published in Pubmed per year (multiplied by a factor of 105 for readability). They are then
divided by the following ratio: (total numbers of papers published in category X between 2001-2010)/(total
numbers of papers published in category “Semantic Web” between 2001-2010).
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PURL identifiers for terms from OBO ontologies and NCBO. However, even when basic
entity types such as genes, proteins, and biological processes can be unambiguously
named through either ontology or Shared Name identifiers, the process of alignment of
data and semantics across domains and disciplines remains a challenge. It is this alignment
or mapping process that is the most challenging to any data integration effort, and crucial
to the success of efforts in research areas such as translational medicine and systems biol-
ogy. When researchers attempt to align and integrate data from different sources, they are
faced with the question of precisely what the data means - the semantics are not usually
explicitly recorded during data collection and data management. What type of relation
does a row in a spreadsheet from a microarray image analysis program represent? Does it
simply represent the “gene expression” or a statistically interpreted (by an algorithm)
measurement of fluorescence that is associated with the mRNA levels of the probe? If
there are no previous examples of RDF representation for the data, the work of represen-
tation, choice of vocabularies, and alignment must occur at the time of data integration.
In other words, data integration is challenging precisely because it requires semantic
commitment and alignment, as well as the requisite understanding of the data.
The “complexity ceiling”
Life sciences researchers have been early adopters of Semantic Web technologies.
Many biomedical information resources are already available in RDF, some providing
resolvable URIs (Uniform Resource Identifiers) and references to external resources.
Within the datasets which are “integrated” using Linked Open Data [32], datasets
related to life sciences account for less than the 10% of triples, but for more than the
50% of total outgoing links.
These results, however, may not be enough. Biomedical information is complex. It is
related to a variety of disciplines which still lack a common language, and it cannot rely
on a single domain of shared concepts as the basis of data integration: there is no common
coordinate system such as that used in geographical map-based data mashups. Although
chromosome position can work, as a common basis for comparison for many gene expres-
sion-related data [33], the genome cannot be used as a reference for all biological data
integration. In another example, even a coordinate space for comparison of anatomical
location remains a challenge: see efforts to normalize coordinate spaces across different
sources of instrumentation for brain scans [34].
The diffusion of the Semantic Web in the life sciences could be bound by the
normalization of knowledge representations and common identifiers, requiring an
unprecedented degree of consensus across disciplines.
The need for incentives and facilitators
Biomedical sciences have been a forerunner in the adoption of Open Access policies
for publications and they went further: both major journals and grant agencies require
the most relevant data to be released in public repositories by using standard formats.
There is, however, no incentive for these repositories to open their information in a
common, machine-processable format, such as RDF. Biomedical public repositories are
like “open silos”: they store public data and provide APIs for programmatic access, but
they lack a common representation. This is in contrast to the commitment to an open
data infrastructure which has been recently adopted by such entities as the UK and US
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government for their own data: when stakeholders of such relevance start to publish
information in open formats, they act as facilitators in the adoption of technologies
and standards. The life sciences perhaps also need facilitators. Take for instance the
requirement for stable, resolvable, URIs by major database providers, which is perhaps
one of the most relevant steps to boost the development of Semantic Web technolo-
gies. There is a general lack of resources and motivation for the database providers to
create and maintain such URIs, not to mention the need to coordinate with other con-
sistent implementations. As a result, much of the initial experimental linked data has
involved unresolvable URIs that employ ad hoc URI formats, e.g. “http://mysemweb.org/
foo/name”. Shared Names [35], an initiative meant to supply permanent URIs that refer
to information records in major databases with a uniform approach and federation of
PURL (permanent URL) servers, is setting up common identifiers that will ease data
integration and data sharing.
While the uptake of Semantic Web technologies in the life sciences is gradually pro-
gressing, the endorsement by granting agencies, by major journals as well as by main
information providers would make it more agile and coordinated.
A change in paradigm
Occasionally, a lack of progress is lamented when discussing the Semantic Web. As a
point of comparison, consider the evolution of relational databases (RDBs). Codd’ s
original publication “A Relational Model of Data for Large Shared Data Banks” [36]
was published in 1970 and the associated query language, SQL, has been standardized
since 1986, with a variety of database implementations that now define data manage-
ment practice for many companies and institutions. However, relational databases only
became commonplace on industry servers in the 1990’ s, with confidence in reliability
and experience in scalability growing into the following decade, when RDBs became a
common fixture on personal computers. Clearly, it can take quite a few years for a
new technology to be widely adopted and become stable. More recently, SGML was
defined as a standard for mark-up of data in 1986. It led to the development of XML
which, in turn, was standardized in 1998.
The establishment of new information representation paradigms therefore requires
time. The Semantic Web is relatively young (RDF was first proposed in 1999, OWL in
2004 and OWL2 in 2009) and, in pursuing the development of the web into a distribu-
ted knowledge base, it proposes a major change of paradigm. The Semantic Web for
instance moves away from the document and process metaphors, which are common in
information systems: it is based on the properties of entities identified by URIs, not on
the “containers” of such properties (i.e. documents that refer to the entities and their
properties). The Semantic Web also makes explicit that the extent of information is
unknown: when looking for information on the Web, it is even intuitively clear that
what is found is only a subset of existing information. This is not the general assumption
which is expected from an information resource.
When is the revolution scheduled?
With 200 ontologies being served from NCBO’ s APIs and SPARQL endpoint, shouldn’t
there already be a Semantic Web revolution in life sciences? Not yet. The ability to
seamlessly incorporate knowledge resources for biomedical informatics has been
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reached neither by bench users nor by application developers. Essential types of life
sciences data such as those related to biomarkers, microarrays, mass spectrometry, and
many types of fluorescent imaging, are still accessed from domain-specific applications
that work with specialized data formats, without any support for semantics and RDF. In
order to reach medical and bioinformatics practitioners, RDF must be incorporated
transparently, “under the hood”, into the most popular applications, without requiring
users to know about the underlying technologies such as OWL, RDF, and SPARQL. The
appropriate semantic types for any given study should ideally be semi-automatically
derived and assigned during the course of data collection and analysis in order to avoid
uncertainty about the semantics later. The incorporation of explicit semantics into appli-
cations and even data collection requires a “long view” toward the potential that all arte-
facts of research, from data to software, should eventually be reusable. Even without a
Semantic Web that spans the globe, the benefits of semantic disclosure can be enjoyed
within the enterprise and the department, where the cost of reusing code and sharing
data is lowered to the point that it actually becomes viable. However, the benefits of a
Semantic Web approach have yet to reach many managers and application developers in
bioinformatics, most of whom continue to encode implicit semantics into application
logic and databases. Perhaps, the Semantic Web in life sciences is just beyond its hype,
and it is in the phase where new effective solutions are starting to emerge: while
“Semantic Web” is less frequently cited in biomedical publications, statistics which can
be related to its use, such as the number of tools and their downloads, are increasing.
The Killer application
It probably will not be a single “killer application” that brings us to the “inflection
point” that tips data toward a full incorporation of semantics and RDF - there are too
many application domains and data types for any single application to bring bioinfor-
matics or biomedical research over the threshold.
To trace a comparison, an XML revolution has already quietly taken place and most
applications now export and import data in some XML format, without the need for spe-
cial parsers - XML did not require a “killer app”. A similarly quiet Semantic Web revolu-
tion will reach life scientists at the bench, likely after it has been used to integrate across
departmental boundaries in the health care clinics, where there seems to be more incentive
and means for integration of patient data. In order to reach the life sciences, the RDF repre-
sentation for each data and instrumentation type must be created and export functionality
incorporated into the most important applications. For example, when microarray data can
be loaded in RDF directly from ArrayExpress or GEO into an R library that then automati-
cally saves the lists of differentially expressed genes along with their p-values into a triple
store (and automatically upload the same explicit information to ArrayExpress and GEO to
be associated with a publication), without requiring the data analyst or bioinformatician to
know anything about OWL or SPARQL, then the groundwork will have been laid for
(automatically) linking microarray study results to other types of biological knowledge.
The role of pharma
With the pharmaceutical industry hitting the “Intellectual Property cliff” for many
drugs (i.e. where they can no longer collect fees for the use of therapeutic compounds
they have developed), there seems to arise a corresponding shift toward data sharing.
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In a keynote address to the Life Sciences Momentum conference in the Netherlands
[37], David Cox of Pfizer convincingly described the strategic importance of partnering
with data stewards in academia in the search for genetic variants in biobanks, with
transparency and agreement to publish results to the public domain. Also, the Pistoia
Alliance [38], with many big pharmaceutical members, aims to pool pre-competitive
information resources among pharmaceutical companies. The trend continues in the
form of the Innovative Medicine Initiative (IMI) [39], European grants with pharma
matching sponsorship. Many of the funded projects are looking at how they can share
data. In order to share data, organizations must agree on the vocabularies and seman-
tics that they will use to annotate or “package” their resources for sharing. Welcome to
the Semantic Web. Not as a visionary and revolutionary tool this time, but as a more
mature Semantic Web, with more resources and a clearer focus for its applications.
A work in progress
In this special issue of the Journal of Biomedical Semantics we present selected papers
from the SWAT4LS workshop held in Amsterdam on November 20th, 2009. We see
in these papers how the Semantic Web is increasingly being adopted to support the
definition of biomedical ontologies, to map between the OBO and OWL ontology lan-
guages [31], or to provide a Logic-bases assessment of the compatibility of UMLS
ontology sources [40]. We see how it may support the organization of information
resources and processes, as in the semantic-based composition of EMBOSS services
[41] or in mining semantic networks of bioinformatics e-resources from the literature
[42]. Finally, we see how the Semantic Web is reaching new areas in life sciences, as a
result of linking the resource description framework to chemioinformatics and proteo-
chemometrics [43].
The diffusion of the Semantic Web in life sciences is a work in progress and is
bounded by how easily it can be understood and used by a large number of users. The
Semantic Web is inherently simple, but some concepts and terminologies can be
confusing, especially because many developers in life sciences are familiar with the
object-oriented paradigm and XML. Without a proper introduction, it is easy to mis-
understand the role and relations between XML, RDF and OWL. Also, without an
introduction to the proper technology, a task such as data integration can become
more challenging than necessary. Thus, the adoption of the Semantic Web in the life
sciences is effectively bound by the availability of specialized courses, tutorials, and
introductory books which can easily reach bioinformaticians and researchers in the life
sciences, and which can convey a key message: the Semantic Web is simple.
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